Comparative cost-effectiveness of focal and total salvage (125)I brachytherapy for recurrent prostate cancer after primary radiotherapy

por Peters, Max, Piena, Marjanne A., Steuten, Lotte M.G., van der Voort van Zyp, Jochem R.N., Moerland, Marinus A., van Vulpen, Marco
Publicado 2016

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer

por Van Son, Marieke J, Peters, Max, Moerland, Marinus A, Noteboom, Juus L, Eppinga, Wietse S, Davila Fajardo, Raquel, Lagendijk, Jan, Van der Voort van Zyp, Jochem R
Publicado 2018

Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study

por Willigenburg, Thomas, Beld, Ellis, Hes, Jochem, Lagendijk, Jan J.W., de Boer, Hans C.J., Moerland, Marinus A., van der Voort van Zyp, Jochem R.N.
Publicado 2020

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer

por Maenhout, Metha, Peters, Max, van Vulpen, Marco, Moerland, Marinus A., Meijer, Richard P., van den Bosch, Maurice A. A. J., Nguyen, Paul L., Frank, Steven J., van der Voort van Zyp, Jochem R. N.
Publicado 2017

Development and internal validation of multivariable prediction models for biochemical failure after MRI-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prosta...

por Willigenburg, Thomas, van Son, Marieke J., van de Pol, Sandrine M.G., Eppinga, Wietse S.C., Lagendijk, Jan J.W., de Boer, Hans C.J., Moerland, Marinus A., van der Voort van Zyp, Jochem R.N., Peters, Max
Publicado 2021